This is an oral medication in tablet form.
Mayzent® is an immune system-modulating therapy thought to act by retaining certain white blood cells in the body's lymph nodes, keeping them out of circulation and out of the central nervous system. Mayzent® also enters the central nervous system (brain and spinal cord) where it may have direct anti-inflammatory and/or other effects.
Mayzent® is approved by the FDA for relapsing forms of multiple sclerosis, which include clinically isolated syndrome, relapsing-remitting disease (RRMS) and active secondary progressive disease (SPMS with relapses).
to read the Prescribing Information for healthcare providers and scroll to page 22 for the medication guide for patients.
® Patient Support Program
Financial Assistance ProgramAlongside MS™